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Photodynamic therapy (PDT) and waterfiltered infrared A
(wIRA) in patients with recalcitrant common hand and
foot warts
PhotodynamischeTherapie(PDT)undwassergefiltertesInfrarotA(wIRA)
bei Patienten mit therapierefraktären vulgären Hand- und Fußwarzen
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Background: Common warts (verrucae vulgares) are human papilloma
virus (HPV) infections with a high incidenceand prevalence, most often
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light (VIS) to stimulate an absorption band of endogenously formed
protoporphyrinIX.AdditionalexperiencesaddingwaterfilteredinfraredA
(wIRA) during 5-ALA-PDT revealed positive effects. 1 Department of Dermatology
and Allergology, Friedrich Aim of the study: First prospective randomised controlled blind study
including PDT and wIRA in the treatment of recalcitrant common hand
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Comparisonof"5-ALAcream(ALA)vs.placebocream(PLC)"and"irradi-
ation with visible light and wIRA (VIS+wIRA) vs. irradiation with visible
light alone (VIS)".
2 Institute of Sports Sciences,
Johann Wolfgang Goethe
University, Frankfurt/Main,
Germany Methods: Pre-treatment with keratolysis (salicylic acid) and curettage.
PDT treatment: topical application of 5-ALA (Medac) in "unguentum
emulsificansaquosum"vs.placebo;irradiation:combinationofVISand
a large amount of wIRA (Hydrosun
® radiator type 501, 4 mm water cu-
vette, waterfiltered spectrum 590-1400 nm, contact-free, typically
painless) vs. VIS alone. Post-treatmentwith retinoic acid ointment.One
tothreetherapycyclesevery3weeks.Mainvariableofinterest:"Percent
change of total wart area of each patient over the time" (18 weeks).
Global judgement by patient and by physician and subjective rating of
feeling/pain (visual analogue scales).
80 patients with therapy-resistant common hand and foot warts were
assignedrandomlyintooneofthefourtherapygroupswithcomparable
numbers of warts at comparable sites in all groups.
Results: The individual total wart area decreased during 18 weeks in
group 1 (ALA+VIS+wIRA) and in group 2 (PLC+VIS+wIRA) significantly
more than in both groups without wIRA (group 3 (ALA+VIS) and 4
(PLC+VIS)): medians and interquartile ranges:
-94% (-100%/-84%) vs. -99% (-100%/-71%) vs. -47% (-75%/0%) vs.
-73% (-92%/-27%).
After 18 weeks the two groups with wIRA differed remarkably from the
two groups without wIRA: 42% vs. 7% completely cured patients; 72%
vs. 34% vanished warts.
Global judgement by patient and by physician and subjective rating of
feeling was much better in the two groups with wIRA than in the two
groups without wIRA.
Conclusions:Theabovedescribedcompletetreatmentschemeofhand
and foot warts (keratolysis, curettage, PDT treatment, irradiation with
VIS+wIRA, retinoic acid ointment; three therapy cycles every 3 weeks)
proved to be effective. Within this treatment scheme wIRA as non-inva-
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Research Article OPEN ACCESSsive and painless treatment modality revealed to be an important, ef-
fective factor, while photodynamic therapy with 5-ALA in the described
form did not contribute recognisably - neither alone (without wIRA) nor
in combination with wIRA - to a clinical improvement.
For future treatment of warts an even improved scheme is proposed:
one treatment cycle (keratolysis, curettage, wIRA, without PDT) once a
week for six to nine weeks.
Keywords:warts,waterfilteredinfraredA(wIRA),photodynamictherapy
(PDT), 5-aminolevulinic acid (5-ALA), human papilloma virus (HPV)
Zusammenfassung
Hintergrund: Vulgäre Warzen (Verrucae vulgares) sind humane Papil-
lomvirus-Infektionen(HPV) mit einer hohen Inzidenz und Prävalenz, die
am häufigsten Hände und Füße befallen und die in der Lage sind, die
Lebensqualitätzubeeinträchtigen.Etwa30inderLiteraturbeschriebene
Therapieverfahren zeugen von einem Mangel an einer einzigen über-
zeugendenStrategie.JüngsteVeröffentlichungenzeigtenpositiveErgeb-
nisse der Photodynamischen Therapie (PDT) mit 5-Aminolävulinsäure
(5-ALA)inderTherapievonHPV-induziertenHautkrankheiten,besonders
Warzen, wobei sichtbares Licht (VIS) verwendet wird, um ein Absorpti-
onsbanddesendogenaus5-ALAgebildetenProtoporphyrinIXzustimu-
lieren.WeitereErfahrungen,wassergefiltertesInfrarotA(wIRA)während
der5-ALA-PDTzusätzlichanzuwenden,offenbartenpositiveWirkungen.
Ziel der Untersuchung: Erste prospektive randomisierte kontrollierte
Blind-Studie,diePDTundwIRAindieBehandlungvontherapierefraktä-
ren vulgären Hand- und Fußwarzen einbezieht.
Vergleichvon"5-ALA-Salbe(ALA)vs.Placebo-Salbe(PLC)"und"Bestrah-
lung mit sichtbarem Licht und wIRA (VIS+wIRA) vs. Bestrahlung mit
sichtbarem Licht allein (VIS)".
Methoden:VorbehandlungmitKeratolyse(Salizylsäure)undKürettage.
Photodynamische Therapie (PDT): topische Applikation von 5-ALA (Me-
dac) in "Unguentum emulsificans aquosum" vs. Placebo; Bestrahlung:
Kombination von sichtbarem Licht (VIS) und einem hohen Maß an
wassergefiltertem Infrarot A (wIRA) (Hydrosun
®-Strahler Typ 501, 4 mm
Wasserküvette,wassergefiltertesSpektrum590-1400nm,kontaktfrei,
typischerweiseschmerzlos)vs.sichtbaresLicht(VIS)allein.Nachbehand-
lung mit Vitamin-A-Säure-Salbe.Ein bis drei Therapiezyklenim Abstand
von 3 Wochen. Hauptzielvariable: "Prozentuale Änderung der Gesamt-
warzenflächejedesPatientenüberdieZeit"(18Wochen).GlobalesUrteil
von Patient und von Arzt sowie subjektive Einschätzung von Empfin-
dung/Schmerz (visuelle Analogskalen).
80 Patienten mit therapierefraktären vulgären Hand- und Fußwarzen
wurdenrandomisierteinerdervierBehandlungsgruppen(mitvergleich-
barer Anzahl an Warzen in vergleichbaren Lokalisationen in allen
Gruppen) zugeteilt.
Ergebnisse: Die individuelle Gesamtwarzenfläche nahm während 18
Wochen in Gruppe 1 (ALA+VIS+wIRA) und in Gruppe 2 (PLC+VIS+wIRA)
signifikant mehr als in den beiden Gruppen ohne wIRA (Gruppe 3
(ALA+VIS) und 4 (PLC+VIS)) ab: Mediane und Interquartil-Spannen:
-94% (-100%/-84%) vs. -99% (-100%/-71%) vs. -47% (-75%/0%) vs.
-73% (-92%/-27%).
Nach18WochenunterschiedensichdiezweiGruppenmitwIRAdeutlich
von den zwei Gruppen ohne wIRA: 42% vs. 7% komplett geheilte Pati-
enten; 72% vs. 34% völlig verschwundene Warzen.
DasglobaleUrteilvonPatientundvonArztunddiesubjektiveEinschät-
zung des Empfindens waren in den zwei Gruppen mit wIRA viel besser
als in den zwei Gruppen ohne wIRA.
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Hand-undFußwarzen(Keratolyse,Kürettage,PhotodynamischeThera-
pie,BestrahlungmitVIS+wIRA,Vitamin-A-Säure-Salbe;dreiTherapiezy-
klen im Abstand von 3 Wochen) erwies sich als effektiv. Innerhalb des
TherapieschemaszeigtesichwIRA-alsnicht-invasiveundschmerzlose
Therapiemodalität - als ein wichtiger, effektiver Faktor, während die
Photodynamische Therapie mit 5-ALA in der beschriebenen Form nicht
erkennbar - weder alleine (ohne wIRA) noch in Kombination mit wIRA -
zu einer klinischen Verbesserung beitrug.
FürdiezukünftigeBehandlungvonWarzenwirdeinweiterverbessertes
Schemavorgeschlagen:einTherapiezyklus(Keratolyse,Kürettage,wIRA,
ohne PDT) einmal pro Woche für sechs bis neun Wochen.
Schlüsselwörter: Warzen, wassergefiltertes Infrarot A (wIRA),
PhotodynamischeTherapie(PDT),5-Aminolävulinsäure(5-ALA),humanes
Papillomvirus (HPV)
Introduction
Commonwarts(verrucaevulgares)arehumanpapilloma
virus (HPV) infections with a high incidence and preva-
lence, most often affecting hands and feet, being able to
impair quality of life of the patients by unsightly appear-
ance,painandcontagion.About30differenttherapeutic
regimens described in the literature [1], [2], [3] reveal a
lack of a single striking strategy with high efficacy and
low side-effects.
Photodynamic therapy (PDT) is one of the most accepted
procedures with best published evidence of efficacy in
the treatment of warts [4], [5].
At the starting point (June 2001) of an intensive ten
month planning period for this first prospective random-
isedcontrolledblindstudyincludingPDTandwaterfiltered
infrared A (wIRA) in the treatment of common warts, the
following knowledge was already available:
• Stender [6] had published in 2000 a very remarkable
randomised controlled double-blind study showing very
good results of PDT in recalcitrant warts with topical ap-
plication of 5-aminolevulinic acid (5-ALA) compared to
placebotreatment.Sheusedvisiblelight(VIS)tostimulate
an absorption band of protoporphyrin IX, which is endo-
genously transformed out of 5-ALA.
•Somedermatologists,especiallyStrasser[7],reported
- including computer based photodocumentation - very
good results in large numbers of patients with hand and
foot warts: Strassercombineda pre-treatmentwith kera-
tolysis and curettage, a PDT treatment with topical appli-
cation of 5-ALA and a combination of VIS and wIRA (Hy-
drosun
® radiator, type 500), and a post-treatment with
retinoic acid ointment.
PDT is based on the interaction of a photosensitiser with
visible light (defined as within the range 380-780 nm)
andreactingsubstanceswithinthecells(e.g.lipids)either
without oxygen (photooxidative reaction type I) or with
oxygen (photooxidative reaction type II) [8]. Most widely
used in dermatology is a topical application of 5-ALA,
which is endogenously transformed in proliferating cells
(e.g. keratinocytes) into the photosensitiser, protopor-
phyrinIX[5],[6],[8],[9],[10].(Evencombinedirradiation
with visible light and infrared in 5-ALA-PDT has been de-
scribed[11].)Thisprocedureisnon-invasive,repeatable,
andbesidessunburn-likesensations(possiblediscomfort
and itching during irradiation, possible erythema and
photosensibilisation in case of sun exposure during ap-
proximately 1 day after application), free of known side-
effects [12], [13], [14], [15]. Especially the discomfort
during irradiation seems to depend upon the spectral
propertyoftheusedradiator(e.g.unfilteredinfraredparts
of radiation and total thermal burden to the skin).
Waterfiltered infrared radiation, especially waterfiltered
infraredA(wIRA,within780-1400nm),allows-compared
tounfilteredheatradiationofconventionalinfraredbulbs
withlargeamountsofinfraredB(definedas1400-3,000
nm) and C (defined as 3,000-1,000,000 nm) - a multiple
energy transfer into tissue without irritating the skin. The
filter effect of water decreases those parts of infrared
radiation (absorption bands of water within infrared A
and most parts of infrared B and C), which would bring -
by reacting with water molecules in the skin - only a
thermal burden to the surface of the skin. wIRA mainly
consists of radiation with good penetration into tissue,
similar to sun heat radiation in moderate climatic zones,
which is filtered by water vapour in the atmosphere.
Technically wIRA is produced in special radiators, whose
wholeincoherentradiationofa3,000kelvinhalogenbulb
is passedthrough a cuvette, containingwater (absorbing
the described undesired wavelengths): the resulting
spectrum with visible light (VIS) and wIRA is shown in
Figure 1.
wIRA produces a therapeutically usable field of warmth
in tissue by (i) good penetration of this radiation into the
depth of tissue, by (ii) reaching capillaries near the sur-
faceandbytransportofwarmthbybloodflowintodeeper
layers, by (iii) increasing bloodflow near the surface and
increasingbythisthesecondmechanism,by(iv)conduc-
tionofwarmthintothedepth,andby(v)increasedenergy
production (metabolism) of tissue caused by increased
temperature. Beside these thermal effects infrared A -
even with very small irradiance intensity and in the un-
filtered form - is able to stimulate cells and evoke a cas-
cade of reactions [16], [17], [18], [19], [20], [21].
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® 501 and Protoporphyrin IX (PPIX)
Hydrosun
®: Calculated for Hydrosun
® 501 with 4 mm water cuvette and orange filter OG590 at 250 mW/cm² (= 2.5 x 10
3 W/m²)
total irradiance intensity, from Measurement of University of Applied Sciences Munich, dated 30th June 1999
PPIX: Qualitative presentation (e.g. only relative scaling of ordinate scale) for comparison of absorption diameter
of protoporphyrin IX (PPIX) monomeres in DMSO [25]
In the planning phase of this study - taking all available
informationinpublishedorunpublishedformintoaccount
- the following two aims were achieved: first: to describe
apracticaloptimisedtreatmentprocedure(includingpre-
and post-treatment) for recalcitrant HPV-induced hand
and foot warts on the basis of PDT and waterfiltered in-
frared A. Second: to create a design for the study.
Aim of the study
Performing a prospective randomised controlled blind
study including PDT and wIRA in the treatment of recalci-
trant common hand and foot warts.
Comparison of "5-ALA cream (ALA) vs. placebo cream
(PLC)" and "irradiation with visible light and wIRA
(VIS+wIRA) vs. irradiation with visible light alone (VIS)".
Methods and design
Leading aspects of study design
• All aspects of therapy (pre-treatment, PDT treatment,
and post-treatment) were given in the same optimised
mannertoallgroupsofpatientswiththeexceptionofthe
two mentioned factors, resulting in 4 therapy groups:
Group1:20%5-ALAcream+VIS+wIRA=ALA+VIS+wIRA
(= PDT + wIRA)
Group 2: Placebo cream + VIS+wIRA = PLC + VIS+wIRA
Group3:20%5-ALAcream+VIS=ALA+VIS(="standard
PDT")
Group 4: Placebo cream + VIS = PLC + VIS
This scheme gives the best possibility to examine the ef-
fectsof5-ALA-PDT,theeffectofwIRA,andtheinteraction
of both, when embedded in an optimal setting of pre-
treatmentandpost-treatment.Thisgivesthebestchance
to avoid overestimation of effects as all results can be
evaluated relative to the minimally treated group 4 (get-
ting keratolysis, curettage, placebo cream, visible light
irradiation, and retinoic acid ointment), which can be ex-
pected to be better than the spontaneous course.
• In order to avoid severe biomathematical and interpre-
tational problems, as seen in the already mentioned re-
markable study of Stender [6], randomised assignment
totherapeuticalgroupswasnotdoneforindividualwarts,
but for patients (= all warts of a patient are assigned to
the same treatment), as the bearer of characteristics is
the patient and not the wart. This is the appropriate bio-
mathematical way to exclude possible systemic interac-
tions between different treatments of different warts
within the same patient.
• 80 patients were randomised within 10 time blocks of
8 patients to the four therapy groups purely on the se-
quenceofthepatientsbeingincludedinthestudy(=after
checkingallinclusionandexclusioncriteria).Thismeans,
that there is no stratification with regard to the location
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longing to each of the four therapeutic groups: smallest
possible block size which allows no information about
the allocation of another patient of the same time block
to a therapy group, not even that he or she belongs to a
different therapy group.)
Inclusion and exclusion criteria
•Inclusioncriteriawere(i)voluntaryparticipation,(ii)age
between18and65years,(iii)anysex,(iv)wartsonhands
and/or feet, clinically verified, resistant to at least one
previous therapy, (v) preceding therapies of any type had
to be unsuccessful for two months and they had to be
discontinued at least 4 weeks before the start of the
study, (vi) agreement not to use other therapies during
the study, (vii) given written informed consent (with pos-
sibility to withdraw from the study at any time without a
negativeimpactontheirfurthertreatmentattheDepart-
ment of Dermatology, Jena).
• Exclusioncriteria were (i) immunosuppressive therapy,
(ii) internal and/or dermatological diseases with sup-
pressedimmunity,(iii)pregnancy,lactation,anduncertain
contraception, (iv) any local therapy of verrucae within
thelast4weeksbeforethestartofthestudy,and(v)lack
of cooperation.
Pre-treatment
• Keratolytic pre-treatment with Guttaplast
® bandages
(6x9cmcontaining1.39gsalicylicacid)[22],[23],being
started by the patients 7 days in advance with foot warts
and 3 days in advance with hand warts until the day of
PDT treatment.
• Abrasion (curettage without bleeding) of well softened
wart tissues by the treating physician in the morning of
the PDT treatment day in order to optimise the penetra-
tion conditions for ALA cream.
PDT treatment
• 5-aminolevulinic acid (5-ALA) was chosen as photo-
sensitiserwithregardtotheworldwidelargeexperiences
with 5-ALA (in a lyophilised, pyrogen-free, sterile form,
produced by Medac GmbH, Wedel, Germany, according
to the guidelines for "good manufacturing practice"). Es-
peciallythe alternative methyl-ALA, which doesnot seem
to bring better penetration, but has to be metabolised to
5-ALA by splitting of a potentially toxic methyl group, was
not chosen.
• Emphasis was on using an optimised galenic prepara-
tion for 5-ALA in order to reach best penetration condi-
tions:
As 5-ALA cream (abbreviated as ALA) was used: 20%
5-aminolevulinicacid(5-ALA)in"unguentumemulsificans
aquosum" (water containing hydrophilic cream, German
pharmacopoeia "DAB 2002"; consisting of: emulgating
cetylstearylalcoholtypeA9.0,viscousparaffin10.5,white
vaseline 10.5, water 70.0).
As placebo cream (abbreviated as PLC) "unguentum
emulsificans aquosum" was used.
The two creams could not be distinguished by inspection
nor by smell.
The creams were applied in a thin, yet occluding layer
(0.2 g/cm²), covering the lesion and also the potentially
subclinically affected areas, at least 5 mm around. A
bandage (Tegaderm
®) was applied over the test areas for
6hours.Afterthisperiodthebandageandresidualcream
was removed (before irradiation).
• In order to have good penetration conditions, the
treated area (hand or foot) had to be kept warm (in
passive manner) from before administering the cream
untilitsremoval,asahighertissuetemperatureincreases
ALApenetrationandproductionofprotoporphyrinIX[24].
• For PDT irradiation two kinds of radiators, one with
VIS+wIRA,onewithVISonly(thelatterservingasradiator
for the control groups 3 and 4), were used, differing only
concerning the missing of wIRA in the emitted spectrum
of the latter, but both radiators emitting the same visible
spectrum (for stimulating the photosensitiser protopor-
phyrin IX). By inspection, the two radiators could not be
distinguished. (As the presence or absence of wIRA can
be felt by the treating physician by comparing the radi-
ation, the study was performed single instead of double
blind.)
Used were Hydrosun
® radiators (Hydrosun
® Medizintech-
nik, Müllheim, Germany, radiator type 501, 4 mm water
cuvette, orange filter OG590, waterfiltered spectrum: in
caseofVIS+wIRA:590-1400nm,incaseofVIS590-780
nm). The distance from the radiator to the treated un-
covered skin area of the patient is standardized by a 25
cm distance rod. At that distance the irradiance intensity
isnearlyhomogeneouswithapproximately250mW/cm²
within a diameter of 10 cm (with the optical axis as cen-
ter),consistingofapproximately60mW/cm²inthevisible
rangeandapproximately190mW/cm²wIRA,whenusing
theradiatorwithVIS+wIRA.(Whenusingtheradiatorwith
VIS only, irradiance intensity is approximately 60
mW/cm², being completely within the visible range.) In
accordance with previous clinical experience in therapy
of verrucae with 5-ALA-PDT [6] and the good acceptance
of wIRA, we choose 30 minutes irradiation, resulting in a
totalradiationdoseof450J/cm²withapproximately110
J/cm² in the visible range and approximately 340 J/cm²
wIRA,whenusingtheradiatorwithVIS+wIRA.(Whenusing
theradiatorwith VIS only, totalradiationdosewasappro-
ximately 110 J/cm², being completely within the visible
range.) If the patient felt warmth to become uncomfort-
able during irradiation, this beginning discomfort could
be stopped by increasing the distance of irradiation by 5
or 10 cm, keeping the durationof irradiationunchanged.
• The form eventually used with the orange filter OG590
(Schott,Mainz,Germany)(usedinbothradiators),exclud-
ing wavelengths below 590 nm, is in accordance with
othercommonradiatorsforPDTwith5-ALA(includingthe
one used by [6]). It uses only one (629 nm) absorption
band of protoporphyrin IX and avoids the severe disad-
vantage of an undesired steeper gradient (from the sur-
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intensity of all absorption bands in case of not using the
orange filter OG590, thus reaching the full spectrum of
awhiteradiationwiththestimulationofallfiveabsorption
bands (approximately 406 nm, 505 nm, 540 nm, 574
nm,629nm[25])ofprotoporphyrinIX(asthefourabsorp-
tion bands towards blue show highest absorption and
effectiveness, see Figure 1 and [25], but lower penetra-
tionintotissuethanthesingleabsorptionbandatapproxi-
mately 629 nm [25]).
• In a limited number of patients of all groups, controls
with Wood's light (approximately 406-407 nm as impor-
tant wavelength to show up red (637 nm) fluorescence
of protoporphyrin IX [26]) before and immediately after
each PDT were planned to document the enrichment of
protoporphyrin IX in wart tissue and to investigate a
bleaching effect caused by irradiation. (Both recent pub-
licationsabout5-ALA-PDTinwarts[6],[10]foundfluores-
cence of intralesionally formed protoporphyrin IX.)
Post-treatment
• Patients were warned not to expose the PDT-treated
areas to direct sunlight for the first 2 days.
• After an interval of 2-3 days, the patients self applied
a retinoic acid ointment (Balisa VAS-Creme
®, containing
120 mg urea and 0.3 mg tretinoin (= retinoic acid) per g
cream) twice daily.
Repetition of treatment cycle
• The entire procedure (pre-treatment, PDT treatment,
andpost-treatment)wasrepeatedafter3weeksandafter
6 weeks, if warts had not cleared by then. Only areas
(including a margin of approximately 5 mm) that differed
inappearancefromsurroundinghealthyskinweretreated
to avoid overtreatment.
The results were controlled after 3, 6, 9, 12 and 18
weeks.
Variables of interest, documentation,
and statistical analysis
• The main variable of interest (to be tested concerning
the whole time period in confirmatory statistics) was the
outcome variable "percent change of total wart area of
each patient over the time". The areas were measured
planimetricallyafterdrawingthemontotransparentfoils,
scanning and analysing with free shareware software
program(ScionImageforWindows,www.scioncorp.com)
[27]. These measurementswere made 0, 3, 6, 9, 12 and
18 weeks after the start of the therapy (t0 defined as
morning of day of first PDT treatment before curettage).
At the same time photodocumentation was taken with
overviewpicturetolocalizeeachwartanddetailedpicture
of each wart.
• Descriptive variables of interest
The aspect of subjective rating (feeling) was assessed
beforeadministeringthecream,6hourslater(=immedi-
atelybeforeirradiation),andimmediatelyafterirradiation
(at 0, 3, 6 weeks, and in addition once at 9 weeks) with
the following question to be answered on a visual ana-
loguescale(VAS):"Howcomfortabledoyoupresentlyfeel
(with respect to pain, burn, itch etc.) about your wart
coveredregion?"(0 = extremelyuncomfortable,100 mm
= free of complaints).
To evaluate the over all judgement separately by the pa-
tient and the physician, the following question to be
answered with VAS was used (after 3, 6 and 9 weeks):
"Howdoyouestimatetheeffectofthetherapy?"(-50mm
=extremedeterioration,0=noeffect,+50mm=extreme
improvement).
Visual analogue scales of 100 mm (well established to
objectivise subjective ratings) have the advantage that
the result can easily be transformed into one of 101 dis-
crete steps, which brings a much higher differentiation
than discrete verbal scales with e.g. a five point scale.
• In order to avoid all problems of parametric statistics
(evendescriptiveparametricstatistics)- e.g.asvariables
in clinical medicine often show an unsymmetrical distri-
bution (this is especially true for the variable "percent
changeoftotalwartareaofeachpatient")-onlymethods
ofnon-parametricstatistics(bothdescriptiveandconfirm-
atory) were used.
• Already in the planning phase it was decided to com-
pare the four treatment groups concerning all clinically
relevant time periods of all variables of interest descrip-
tively (median, percentiles of 25 and 75, minimum,
maximum) and concerning the only main variable of in-
terest in addition the "percent change of total wart area
of each patient between t0 and 18 weeks" confirmatorily
withthenon-parametricMann-WhitneyUtestforunpaired
samples. The total error probability was set to 0.05 (5%),
applying Bonferroni alpha-error correction with alpha* =
alpha/4, as the following four comparisons should be
evaluated:group1vs.group4,group2vs.group4,group
3 vs. group 4, group 1 vs. group 2. Statistical analysis
wasperformedwiththeGraphPadPrism4.0forWindows
package (San Diego, USA).
Realisation
Prospective,randomised,controlled(2factors[radiation,
photosensitiser] controlled [VIS+wIRA vs. VIS, 5-ALA vs.
Placebo], four armed) study in patients with therapy-re-
sistant common warts on either hands and/or feet.
The protocol was approved by the Ethics Committee of
the Friedrich Schiller University, Jena.
FromMay2002toOctober2002,80patients(51female,
29male,medianage31(range18-63)years,seefurther
characterizationinTable1),fulfillingtheinclusioncriteria
and none of the exclusion criteria, were assigned ran-
domly into one of the four therapy groups (4 x 20) with
comparable numbers of warts at comparable sites in all
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(given as number and percentage or otherwise as percentile of 25, median, percentile of 75 and range (minimum to maximum))
groups and treated in the described form. The 581 hand
and foot warts were of different sizes and categories, in-
cludingsmalltolargesolitarylesionsandmultiplelesions
in clusters of mosaic warts, and the median duration of
warts at entry was 24 (range 6-192) months.
Compliance with treatment was excellent. Especially no
single patient complained pain after administering the
cream nor during or after the irradiation.
8 patients did not continue to participate after one
treatment, additional 3 after two treatments (in one pa-
tient caused by a change in living area), one patient did
not show up for the controls after the third treatment: in
total12patientsdidnotcontinuetilltheendofthestudy.
No systematic differences between the drop outs and
theirgroups,towhichtheybelonged,wereseen.Perhaps
thenumberofdropoutsinthegroups3and4washigher
due to the smaller therapeutic effect.
So out of the 80 patients, 68 completed the entire study
(43 female,25 male)with a medianageof32 (range18-
63) years and a total of 500 hand and foot warts; the
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months. Within these 68 patients, 19 patients with 104
warts belonged to group 1 (ALA+VIS+wIRA), 19 patients
with 141 warts to group 2 (PLC+VIS+wIRA), 14 patients
with 125 warts to group 3 (ALA+VIS), and 16 patients
with130wartstogroup4(PLC+VIS).Allpresentedresults
refer to these 68 patients.
All 68 patients received 3 therapy cycles, as no patient
was free of warts after three weeks and the first 6 pa-
tients being free of warts after 6 weeks showed a slight
remaining hyperkeratosis and were therefore treated to
be on the safe side.
Results
Embedded in the whole treatment scheme of hand and
foot warts (keratolysis, curettage, PDT treatment, irradi-
ationwithVIS+wIRA,retinoicacidointment;threetherapy
cycles every 3 weeks), wIRA alone as well as in combina-
tion with ALA-PDT reduced the "total wart area of each
patient"significantlyandincreasedthecurerateremark-
ably:
Results, when looking at the whole time period between
beginning (t0) and week 18:
In group 1 (ALA+VIS+wIRA) and in group 2
(PLC+VIS+wIRA) the "total wart area of each patient" de-
creased significantly more than in both groups treated
with visible light without wIRA (groups 3 and 4). The rela-
tive reduction (in percent) of "total wart area of each pa-
tient"withinthe4therapygroupsisshowninTable2and
Figure 2.
Group1(ALA+VIS+wIRA)hadasignificantlyhigherreduc-
tion of the "total wart area of each patient" (p = 0.0103)
compared to group 4 (PLC+VIS).
InpatientstreatedwithPLC+VIS+wIRA(group2)the"total
wart area of each patient" decreased significantly more
in comparison to patients treated with PLC+VIS (group
4) (p = 0.0107).
There was no significant difference between group 3
(ALA+VIS) and 4 (PLC+VIS) in reduction of the "total wart
area of each patient". Also between group 1
(ALA+VIS+wIRA) and group 2 (PLC+VIS+wIRA) no signifi-
cant difference occurred.
After 18 weeks in the two groups with wIRA (group 1 and
group 2) 16 out of 38 patients (42%) were completely
free of warts compared to only 2 out of 30 patients (7%)
in the two groups without wIRA (group 3 and group 4)
(see details in Table 3). (All completely cured patients,
who could be followed up one year later, remained free
of warts.)
After 18 weeks in the two groups with wIRA (group 1 and
group 2) 19 out of 38 patients (50%) were completely
free of warts or with a remaining total wart area of less
then 5% of the initial total wart area compared to only 2
out of 30 patients (7%) in the two groups without wIRA
(group 3 and group 4) (see details in Table 4).
After 18 weeks in the two groups with wIRA (group 1 and
group 2) 177 out of 245 warts (72%) had vanished
completely (= median of 100% of reduction of "single
wart area") compared to only 86 out of 255 warts (34%)
in the two groups without wIRA (group 3 and group 4)
(see details in Table 5).
The greatest part of these improvements was already
achieved after 9 weeks (see details in Tables 3, 4, 5).
Eventhelargestsinglewart(aplantarfootwartwith4068
mm
2ingroup2)hadbeenvanishedalreadyafter6weeks.
The effect of therapy as estimated by patients and by
physician separately in form of a rating given in a visual
analogue scale (from -50 to +50) showed great improve-
ment in the two groups with wIRA and much smaller ef-
fects in the two groups without wIRA: e.g. medians of es-
timation of effect of therapy by physician after 9 weeks:
+41 (group 1), +41 (group 2); +0 (group 3), +0 (group 4)
(see details in Figure 3A+B).
The complaints in the wart covered regions as estimated
by the patients improved in the course of the study in all
groups, but most in group 1 and 2: e.g. medians of sub-
jective rating of feeling (visual analogue scale from 0
(=extremelyuncomfortable)to100(=freeofcomplaints))
after 9 weeks: 85 (group 1), 99 (group 2); 50 (group 3),
32 (group 4) (see details in Figure 4). Patients with warts
located on the soles of the feet and near nails often had
a lot of pain. Only after one treatment with wIRA their
complaints decreased within 3 weeks.
Within the treatmentdays the subjective rating of feeling
didnotchangebetween"beforeadministeringthecream",
"6 hours later (= immediately before irradiation)", and
"immediately after irradiation" (therefore Figure 4 shows
only 1 assessment time per day): Remarkably patients
did not feel any pain during nor after treatment.
Figure 5A-D shows pictures as an example of the course
oftreatmentofhandwarts:beforestartingwithtreatment
(with PLC+VIS+wIRA), after 3, 6 and 18 weeks.
Figure 6A-D shows pictures as an example of the course
of treatmentof foot warts: beforestarting with treatment
(with ALA+VIS+wIRA), after 3, 6 and 18 weeks.
Discussion
Warts impair quality of life of the patients due to their
unsightly appearance, pain, and the concern that the
warts might spread and be transferred to other people.
The standard therapiesare often invasive and/orpainful
and therefore especially in children traumatising for the
patients. Thus we conducted the present study to en-
hance the reported effect of photodynamic therapy in
warts combining it with wIRA. Generally irradiation with
wIRA may be used with a preventive, regenerative and
therapeutic intention in cases where a warming of deep
tissuelayerswithoutskincontactandwithoutoverheating
of the skin surface is desired. Thus, wIRA is already used
in physiotherapy [28]; sports medicine [29]; internal
medicine [30]; pediatrics [31]; and in dermatology for
delayed wound healing [32], [33] (with cell physiological
basics in [17]), sclerodermia, and penetration enhance-
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between beginning of the treatment (t0= morning of day of first PDT treatment before curettage) and examination day
after 3 (t3w-t0), 6 (t6w-t0), 9 (t9w-t0), 12 (t12w-t0) and 18 (t18w-t0) weeks (given as percentile of 25, median, percentile of 75 and range
(minimum to maximum))
Figure 2: Relative change (in %) of "total wart area of each patient"
between beginning of the treatment (t0 = morning of day of first PDT treatment before curettage) and examination day after 3, 6,
9, 12 and 18 weeks (given as minimum, percentiles of 25, median, percentiles of 75, and maximum (box and whiskers graph))
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after 3 (t3w), 6 (t6w), 9 (t9w), 12 (t12w) and 18 (t18w) weeks
Table 4: Number and percentage of patients completely free of warts or with a remaining total wart area of less then
5% of the initial total wart area
after 3 (t3w), 6 (t6w), 9 (t9w), 12 (t12w) and 18 (t18w) weeks
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after 3 (t3w), 6 (t6w), 9 (t9w), 12 (t12w) and 18 (t18w) weeks
ment of topically applied substances [34], [35], or in
combination with PDT [9], [36].
Photodynamictherapy(PDT)especiallywithtopicalappli-
cation of 5-ALA is well establishedin dermatology [5], [8]
withapplicationsinthetreatmentofactinickeratosisand
basal cell carcinomas. Recently, it has been reported to
beefficientinwarts[6],[10]andcondylomataacuminata
[37]. The combination of wIRA with 5-ALA based PDT has
been reported for the treatment of actinic keratosis and
basal cell carcinoma [9] and HPV-induced hand and foot
warts [7]. The latter application, however, has not been
validated by a randomised and controlled study. Despite
a report of lack of efficacy of single-treatment5-ALA-PDT
in viral warts [6], [38], Stender [6] achieved in the men-
tionedremarkablerandomisedcontrolledstudywiththree
tosixphotodynamictreatmentcycleswith5-ALA-embed-
ded in a treatment with keratolysis and intensive paring
in both groups - after 18 weeks a median of 100% (in-
terquartilerange100%/57%)ofreductionof"singlewart
area", compared to the control group without 5-ALA with
71% (100%/0%) (significant and relevant difference);
56% vs. 42% of all warts vanished completely, demon-
strating superior efficacy of repetitive 5-ALA-PDT com-
pared to placebo-PDT (based on a series of previously
published experiences of this group, showing as well ad-
vantages compared to cryotherapy). As well, Fabbrocini
showed - embedded in a treatment with keratolysis and
curettage - a good effect of topical 5-ALA-PDT performed
weekly for 3 weeks compared to placebo (75% vs. 23%
vanished plantar warts) [10].
Compared to other radiation sources, there is much less
senseofdiscomfortorburningduringirradiationwiththe
Hydrosun
® radiator (in our study no complains occurred
at all), most probably by excluding all kinds of unfiltered
infrared.
This study shows that wIRA - with or without 5-ALA based
PDT - significantly reduces "total wart area of each pa-
tient"of recalcitrantfoot and hand warts and remarkably
increases percentage of vanished warts and completely
cured patients, if embedded in the described complete
treatment scheme (including keratolysis and curettage
as pre-treatment and retinoic acid ointment as post-
treatment) of hand and foot warts. No scars or skin side
effects were observed, and no disturbance of function
was reported by patients after treatment.
The effectofwIRAmay be explainedboth asthermaland
as non-thermal effect:
A thermal effect is the increase in tissue temperature
(building up a well documented field of warmth as de-
scribed in the introduction, e.g. up to approximately 4°C
increase in 10 mm depth of tissue [28]), which might act
directly towards the inactivation of thermolabilic human
papilloma viruses and indirectly by increased tissue
metabolism with following immunomodulatory effects
includingbetterlocalimmunesystemcompetenceofthe
patient. This explanation as thermal effect is supported
by the old experience that heat (and changes between
heatandcold)canbeusedinthetreatmentofwartsand
by published heat treatments of warts with either very
short (one minute) [39] or medium (30-90 minutes) [40]
or long (two hours) [41] procedures, the first probably
more tending towards inactivation, the latter more to-
wards immunomodulation. The explanation as thermal
effect is as well in accordance with the fact that warts
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Fuchs et al.: Photodynamic therapy (PDT) and waterfiltered infrared ...Figure 3A+B: Estimation of the effect of treatment by patients and by physician
("How do you estimate the effect of therapy?") with visual analogue scale VAS (-50 mm = extreme deterioration, 0 = no effect,
+50 mm = extreme improvement)
after3,6and9weeks(givenasminimum,percentilesof25,median,percentilesof75,andmaximum(boxandwhiskersgraph)).
Medians from left to right:
A: VIS+wIRA treated groups (with and without ALA)
Group 1: ALA+VIS+wIRA: +6/ +4, +18/+15, +35/+41
Group 2: PLC+VIS+wIRA: +8/+13, +15/+32, +31/+41
B: VIS treated groups (with and without ALA)
Group 3: ALA+VIS: +0/+0, +0/+0, +1/+0
Group 4: PLC+VIS: +0/+0, +1/+0, +5/+0
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("Howcomfortabledoyoupresentlyfeel(withrespecttopain,burn,itchetc.)aboutyourwartcoveredregion?")withvisualanalogue
scale (VAS) (0 = extremely uncomfortable, 100 = free of complaints) before beginning of the treatment (morning of day of first
PDT treatment before administering the cream) and after 3, 6 and 9 weeks (given as minimum, percentiles of 25, median,
percentiles of 75, and maximum (box and whiskers graph)).
Medians from left to right:
VIS+wIRA treated groups:
Group 1: ALA+VIS+wIRA: 16 / 25 / 40 / 85,
Group 2: PLC+VIS+wIRA: 41 / 50 / 87 / 99,
VIS treated groups:
Group 3: ALA+VIS: 15 / 37 / 33 / 50,
Group 4: PLC+VIS: 18 / 27 / 33 / 32
are most often located on hypothermic areas like hands
and feet.
Beside all these aspects of thermal effects non-thermal
effects of infrared as radiation directly effecting and
stimulating cells seem to be a remarkable second major
part of the explanation. Already Albrecht-Buehler [18]
described cell reactions towards very weak (no thermal
effect causing) infrared radiation sources, later Ehrlicher
[42] reported similarly cell growth towards infrared
sources (800 nm). Effects of special wavelengths within
infrared A (e.g. 820 nm) on cellular substructures, like
cytochrome c, have been described in detail [19], [20],
[21].Especiallythesenon-thermaldirectradiationeffects
wouldbeabletoexplaindifferenteffectslikeimmunomo-
dulation or wound healing improvement even without
large increase of tissue temperature.
We did not find a significantly different therapeutic re-
sponsebetweenwIRAwithorwithout5-ALA(group1with
ALA+VIS+wIRA vs. group 2 with PLC+VIS+wIRA) and no
significantly different therapeutic response between a
standard-PDT (ALA+VIS) and a placebo-PDT (PLC+VIS):
This could mean that ALA, in the present preparation
(although using an optimised but difficult preparation
with unguentum emulsificans aquosum), did not reach
in a sufficient amount the infected tissue or that it was
inactivated (e.g. pH dependent, if pH>5) or that it was
nottransformedinasufficientamountintoprotoporphyrin
IXorprotoporphyrinIXwasinactivated(e.g.bylightahead
of the PDT irradiation). This is in accordance with the
situation, that we did not observe any fluorescence visu-
ally of the treated verrucae vulgares during irradiation
with Wood's light. Both recent publications about 5-ALA-
PDT in common warts [6], [10] found fluorescence of in-
tralesionally formed protoporphyrin IX, but using a fluor-
escence spectrometer. Visually observable fluorescence
of common warts (even with an ideal stimulating Wood's
light) during a well performing 5-ALA-PDT with good clin-
ical results is described as very rare and weak even after
intensivepre-treatment.ThisisinaccordancewithAcker-
mann [25], describing limitations of detectibility of fluor-
escence, e.g. the dependence from concentration ratio
betweenaffectedtissueandsurroundingtissueconcern-
ing protoporphyrin IX [25].
The "relative decrease of total wart area of each patient"
inthetwogroupswithonlyvisiblelightwithoutwIRA(47%
and 73%) was - taking repeated pre-treatment with kera-
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18 year old boy with multiple periungual warts: before starting with treatment (with PLC+VIS+wIRA), after 3, 6 and 18 weeks.
A: Before first treatment, B: Before second treatment, C: Before third treatment, D: 18 weeks after first treatment
Figure 6A-D: Example of foot warts:
29 year old man with a solitary plantar foot wart: before starting with treatment (with ALA+VIS+wIRA), after 3, 6 and 18 weeks.
A: Before first treatment, B: Before second treatment, C: Before third treatment, D: 18 weeks after first treatment
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retinoic acid ointment into account ([6] reported as well
under paring and keratolysis and placebo-PDT a median
of71%ofreductionofsinglewartarea)-withinanexpec-
tedrangeandwithnonecessitytoexplainarelevantpart
of the decrease by psychological or placebo effects or by
spontaneous remission.
In conclusion, wIRA has been shown to be an effective,
non-invasivetreatmentofrecalcitrantcommonhandand
footwartswhenembeddedinacompleteprocedurewith
pre-treatment(keratolysis,curettage)andpost-treatment
(retinoic acid ointment).
Especially as there are striking differences between the
two groups treated with wIRA compared to the two other
groups (42% vs. 7% completely cured patients; 72% vs.
34% vanished warts) with no additional benefit adding
the time consuming ALA-PDT, the authors propose - in-
cluding own recent experiences after having finished the
presented study - a treatment of recalcitrant common
hand and foot warts with wIRA without ALA-PDT, but em-
bedded in a procedure with pre-treatment and possibly
post-treatment (estimating keratolysis to be essential,
curettage to bring additional benefit, retinoic acid oint-
menttobenegligible),withanevenimprovedresultusing
one treatment cycle (keratolysis, curettage, wIRA) once
a week for six to nine weeks.
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